chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Did not get the second dose within and it has been more than 42 days since 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not get the second dose within and it has been more than 42 days since 1st dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not get the second dose within and it has been more than 42 days since 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not get the second dose within and it has been more than 42 days since 1st dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Scratch, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: She scratches herself so hard that her skin almost kills her; Hardness at injection site; Injection site is very itchy; Swelling at injection site; Redness at injection site; Tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of SCRATCH (She scratches herself so hard that her skin almost kills her), VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE PRURITUS (Injection site is very itchy), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SCRATCH (She scratches herself so hard that her skin almost kills her), VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE PRURITUS (Injection site is very itchy), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Tenderness at injection site). At the time of the report, SCRATCH (She scratches herself so hard that her skin almost kills her), VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE PRURITUS (Injection site is very itchy), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Tenderness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: She scratches herself so hard that her skin almost kills her; Hardness at injection site; Injection site is very itchy; Swelling at injection site; Redness at injection site; Tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of SCRATCH (She scratches herself so hard that her skin almost kills her), VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE PRURITUS (Injection site is very itchy), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SCRATCH (She scratches herself so hard that her skin almost kills her), VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE PRURITUS (Injection site is very itchy), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Tenderness at injection site). At the time of the report, SCRATCH (She scratches herself so hard that her skin almost kills her), VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE PRURITUS (Injection site is very itchy), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Tenderness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nervousness, Tachycardia
Clinical narrative: Nervous about the 2nd dose; Slightly dizzy; Developed a fast heart beat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 22-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Slightly dizzy), TACHYCARDIA (Developed a fast heart beat) and NERVOUSNESS (Nervous about the 2nd dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN D NOS, FISH OIL, ZINC, MAGNESIUM, PROBIOTICS NOS, ELDERBERRY [SAMBUCUS NIGRA] and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced DIZZINESS (Slightly dizzy) and TACHYCARDIA (Developed a fast heart beat). On 22-Mar-2021, the patient experienced NERVOUSNESS (Nervous about the 2nd dose). On 09-Mar-2021, DIZZINESS (Slightly dizzy) and TACHYCARDIA (Developed a fast heart beat) had resolved. At the time of the report, NERVOUSNESS (Nervous about the 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included multi vitamin over 50  On 09 Mar 2021, the patient was also preparing for colonoscopy test for the next day. Second dose was scheduled on 06 Apr 2021.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Hyperglycaemia
Clinical narrative: Morning sugar is up to 135-140 without eating any sugar; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (Morning sugar is up to 135-140 without eating any sugar) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes (Normally, 110 in the morning before vaccine administration.).   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERGLYCAEMIA (Morning sugar is up to 135-140 without eating any sugar). At the time of the report, HYPERGLYCAEMIA (Morning sugar is up to 135-140 without eating any sugar) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 135-140 (High) Morning sugar is up to 135-140 without eating any sugar..         Concomitant product use was not provided by the reporter. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Light fever; Slight chills; A spontaneous report was received from a consumer concerning a 43-year-old, female patient, who received first dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced slight fever and light chills.  The patient had no current condition or medical history. Products known to have been used by the patient, within two weeks prior to the event included unspecified vitamins.   On 04JAN-2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) for prophylaxis of COVID-19 infection.   On 04-JAN-2021, one-hour post vaccination the patient experienced light fever and chills.  On 03-FEB-2021, the patient received her second dose of vaccine mRNA -1273 (Lot number: 029L20A) for prophylaxis of COVID-19 infection. It was reported that the second dose was perfect with no adverse events.  At the time of the report, the patient received both scheduled doses of mRNA-1273; therefore, action taken with the drug in response to the events is not applicable.  The outcome of the events slight fever and light chills was considered as recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Spinal pain
Clinical narrative: shingles; Hard pain in her spinal cord; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) and SPINAL PAIN (Hard pain in her spinal cord) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036ANA) for COVID-19 vaccination.     The patient's past medical history included Lupus erythematosus. Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S), PREDNISONE, CANDESARTAN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced SPINAL PAIN (Hard pain in her spinal cord). On 14-Mar-2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) and SPINAL PAIN (Hard pain in her spinal cord) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. Patient states she has never received shingles vaccination, and she has Lupus.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Pain, Peripheral swelling, Urticaria, Vaccination site erythema
Clinical narrative: It looked like it was getting better but then sevne days later it; now my arm started to swell; the area was red had a knot hot and sore; the area was red had a knot hot and sore.; rash came out on the site; "baseball" sized welt; (welt) sore; redness; local inflammation at the site; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (It looked like it was getting better but then sevne days later it), PERIPHERAL SWELLING (now my arm started to swell), VACCINATION SITE WARMTH (the area was red had a knot hot and sore), VACCINATION SITE INFLAMMATION (local inflammation at the site) and URTICARIA ("baseball" sized welt) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Allergic reaction to drug and Allergic reaction to food. Concomitant products included ESTRADIOL for Hysterectomy, VITAMIN D NOS and PROBIOTICS NOS for an unknown indication.    On 05-Mar-2021 at 8:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (local inflammation at the site) and VACCINATION SITE ERYTHEMA (redness). On 12-Mar-2021, the patient experienced URTICARIA ("baseball" sized welt) and PAIN ((welt) sore). On an unknown date, the patient experienced CONDITION AGGRAVATED (It looked like it was getting better but then sevne days later it), PERIPHERAL SWELLING (now my arm started to swell), VACCINATION SITE WARMTH (the area was red had a knot hot and sore), VACCINATION SITE PAIN (the area was red had a knot hot and sore.) and VACCINATION SITE RASH (rash came out on the site). At the time of the report, CONDITION AGGRAVATED (It looked like it was getting better but then sevne days later it), PERIPHERAL SWELLING (now my arm started to swell), VACCINATION SITE WARMTH (the area was red had a knot hot and sore), VACCINATION SITE INFLAMMATION (local inflammation at the site), URTICARIA ("baseball" sized welt), PAIN ((welt) sore), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (the area was red had a knot hot and sore.) and VACCINATION SITE RASH (rash came out on the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Non significant follow up received on 16-MAY-2021, event added, medical history updated On 21-Jun-2021: Non significant follow up received on 21-JUN-2021, no new information
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site inflammation, Vaccination site pain, Vaccination site rash, Vaccination site warmth
Clinical narrative: It looked like it was getting better but then sevne days later it; now my arm started to swell; the area was red had a knot hot and sore; the area was red had a knot hot and sore.; rash came out on the site; "baseball" sized welt; (welt) sore; redness; local inflammation at the site; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (It looked like it was getting better but then sevne days later it), PERIPHERAL SWELLING (now my arm started to swell), VACCINATION SITE WARMTH (the area was red had a knot hot and sore), VACCINATION SITE INFLAMMATION (local inflammation at the site) and URTICARIA ("baseball" sized welt) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Allergic reaction to drug and Allergic reaction to food. Concomitant products included ESTRADIOL for Hysterectomy, VITAMIN D NOS and PROBIOTICS NOS for an unknown indication.    On 05-Mar-2021 at 8:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (local inflammation at the site) and VACCINATION SITE ERYTHEMA (redness). On 12-Mar-2021, the patient experienced URTICARIA ("baseball" sized welt) and PAIN ((welt) sore). On an unknown date, the patient experienced CONDITION AGGRAVATED (It looked like it was getting better but then sevne days later it), PERIPHERAL SWELLING (now my arm started to swell), VACCINATION SITE WARMTH (the area was red had a knot hot and sore), VACCINATION SITE PAIN (the area was red had a knot hot and sore.) and VACCINATION SITE RASH (rash came out on the site). At the time of the report, CONDITION AGGRAVATED (It looked like it was getting better but then sevne days later it), PERIPHERAL SWELLING (now my arm started to swell), VACCINATION SITE WARMTH (the area was red had a knot hot and sore), VACCINATION SITE INFLAMMATION (local inflammation at the site), URTICARIA ("baseball" sized welt), PAIN ((welt) sore), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (the area was red had a knot hot and sore.) and VACCINATION SITE RASH (rash came out on the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Non significant follow up received on 16-MAY-2021, event added, medical history updated On 21-Jun-2021: Non significant follow up received on 21-JUN-2021, no new information
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Sinusitis
Clinical narrative: sinuses have cleared up; Temperature has returned to normal; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinuses have cleared up) and BODY TEMPERATURE INCREASED (Temperature has returned to normal) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinuses have cleared up) and BODY TEMPERATURE INCREASED (Temperature has returned to normal). At the time of the report, SINUSITIS (sinuses have cleared up) and BODY TEMPERATURE INCREASED (Temperature has returned to normal) outcome was unknown. Probable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). On 18-Mar-2021, PAIN IN EXTREMITY (soreness in arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment information was provided.   This case was linked to INC.-MOD-2021-053195 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: follow-up received on 09-AUG-2021 and contains no new information.; Sender's Comments:  INC.-MOD-2021-053195:Boyfriend's case
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain
Clinical narrative: Achey; Fever; Left arm sore for a weak; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achey), PYREXIA (Fever) and VACCINATION SITE PAIN (Left arm sore for a weak) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (Achey), PYREXIA (Fever) and VACCINATION SITE PAIN (Left arm sore for a weak). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 02-Mar-2021, PAIN (Achey) and PYREXIA (Fever) had resolved. On 08-Mar-2021, VACCINATION SITE PAIN (Left arm sore for a weak) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Her arm barely hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm barely hurt) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN, CLONAZEPAM and ESTRADIOL for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Her arm barely hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Her arm barely hurt) outcome was unknown.            The action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-053183 (Patient Link).
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Nodule, Pain in extremity, Urticaria
Clinical narrative: Hives; Hard knot on the arm of the injection; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), NODULE (Hard knot on the arm of the injection) and PAIN IN EXTREMITY (soreness in arm) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). On 18-Mar-2021, the patient experienced URTICARIA (Hives) and NODULE (Hard knot on the arm of the injection). At the time of the report, URTICARIA (Hives), NODULE (Hard knot on the arm of the injection) and PAIN IN EXTREMITY (soreness in arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  No treatment medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-053192 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up contains significant information : Event added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-053192:girlfriend's case
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain, Vaccination site rash
Clinical narrative: a rash appeared at the injection site; Injection site sore for a couple of days; felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (a rash appeared at the injection site), VACCINATION SITE PAIN (Injection site sore for a couple of days) and FATIGUE (felt a little tired) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site sore for a couple of days) and FATIGUE (felt a little tired). On 19-Mar-2021, the patient experienced VACCINATION SITE RASH (a rash appeared at the injection site). The patient was treated with LORATADINE at a dose of 1 dosage form. On 14-Mar-2021, VACCINATION SITE PAIN (Injection site sore for a couple of days) had resolved. At the time of the report, VACCINATION SITE RASH (a rash appeared at the injection site) and FATIGUE (felt a little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of  vaccination site pain (pain at the injection site) and lymphadenopathy (tenderness in lymph nodes in neck and under armpit) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 9, 2021, patient experienced vaccination site pain (pain at the injection site). On an unknown date, patient experienced lymphadenopathy (tenderness in lymph nodes in neck and under armpit). At the time of the report, vaccination site pain (pain at the injection site) and lymphadenopathy (tenderness in lymph nodes in neck and under armpit) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant product use and treatment information not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm where area injection was warm; Arm where area injection was hard; Arm where area injection was swell; Arm where area injection was red; feeling pain where injection was; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm where area injection was warm), VACCINATION SITE INDURATION (Arm where area injection was hard), VACCINATION SITE PAIN (feeling pain where injection was), VACCINATION SITE SWELLING (Arm where area injection was swell) and VACCINATION SITE ERYTHEMA (Arm where area injection was red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PAIN (feeling pain where injection was). On 21-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Arm where area injection was warm), VACCINATION SITE INDURATION (Arm where area injection was hard), VACCINATION SITE SWELLING (Arm where area injection was swell) and VACCINATION SITE ERYTHEMA (Arm where area injection was red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Arm where area injection was warm), VACCINATION SITE INDURATION (Arm where area injection was hard), VACCINATION SITE PAIN (feeling pain where injection was), VACCINATION SITE SWELLING (Arm where area injection was swell) and VACCINATION SITE ERYTHEMA (Arm where area injection was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. She is a cancer patient on chemo.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Chills, Headache, Myalgia
Clinical narrative: Body pain going down to abdominal area on left side; Felt pain fool touch on left body side; Swelling of lymph nodes on injection side; Chills; Fever 101 degrees Fahrenheit; Headache; Body pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Body pain going down to abdominal area on left side), TENDERNESS (Felt pain fool touch on left body side), VACCINATION SITE LYMPHADENOPATHY (Swelling of lymph nodes on injection side), CHILLS (Chills) and PYREXIA (Fever 101 degrees Fahrenheit) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever 101 degrees Fahrenheit), HEADACHE (Headache), MYALGIA (Body pain) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced ABDOMINAL PAIN (Body pain going down to abdominal area on left side) and TENDERNESS (Felt pain fool touch on left body side). 18-Mar-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swelling of lymph nodes on injection side). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 06-Mar-2021, CHILLS (Chills), PYREXIA (Fever 101 degrees Fahrenheit), HEADACHE (Headache), MYALGIA (Body pain) and NAUSEA (Nausea) had resolved. At the time of the report, ABDOMINAL PAIN (Body pain going down to abdominal area on left side), TENDERNESS (Felt pain fool touch on left body side) and VACCINATION SITE LYMPHADENOPATHY (Swelling of lymph nodes on injection side) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: 101 (High) Fever 101 degrees Fahrenheit.         Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-053174 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Event outcomes were updated.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Tenderness, Vaccination site lymphadenopathy
Clinical narrative: Body pain going down to abdominal area on left side; Felt pain fool touch on left body side; Swelling of lymph nodes on injection side; Chills; Fever 101 degrees Fahrenheit; Headache; Body pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Body pain going down to abdominal area on left side), TENDERNESS (Felt pain fool touch on left body side), VACCINATION SITE LYMPHADENOPATHY (Swelling of lymph nodes on injection side), CHILLS (Chills) and PYREXIA (Fever 101 degrees Fahrenheit) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever 101 degrees Fahrenheit), HEADACHE (Headache), MYALGIA (Body pain) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced ABDOMINAL PAIN (Body pain going down to abdominal area on left side) and TENDERNESS (Felt pain fool touch on left body side). 18-Mar-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swelling of lymph nodes on injection side). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 06-Mar-2021, CHILLS (Chills), PYREXIA (Fever 101 degrees Fahrenheit), HEADACHE (Headache), MYALGIA (Body pain) and NAUSEA (Nausea) had resolved. At the time of the report, ABDOMINAL PAIN (Body pain going down to abdominal area on left side), TENDERNESS (Felt pain fool touch on left body side) and VACCINATION SITE LYMPHADENOPATHY (Swelling of lymph nodes on injection side) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: 101 (High) Fever 101 degrees Fahrenheit.         Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-053174 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Event outcomes were updated.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue
Clinical narrative: Loss of appetite; generally weak; tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), ASTHENIA (generally weak) and FATIGUE (tired) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023N20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FINASTERIDE for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DECREASED APPETITE (Loss of appetite), ASTHENIA (generally weak) and FATIGUE (tired). At the time of the report, DECREASED APPETITE (Loss of appetite), ASTHENIA (generally weak) and FATIGUE (tired) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: A lot of pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A lot of pain in arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (A lot of pain in arm). At the time of the report, PAIN IN EXTREMITY (A lot of pain in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicines were reported. No treatment information were reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Chest pain, Dyspnoea, Feeling abnormal, Hot flush
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (memory problem), HOT FLUSH (hot flashes), DYSPNOEA (trouble in breathing), SARS-COV-2 TEST POSITIVE (covid 19 positive) and CHEST PAIN (chest pain) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN CALCIUM (LIPITOR), ALFUZOSIN HYDROCHLORIDE (ALFUSIN) and METFORMIN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced AMNESIA (memory problem), HOT FLUSH (hot flashes) and DYSPNOEA (trouble in breathing). On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (covid 19 positive), CHEST PAIN (chest pain), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (brain fog) and NAUSEA (Nausea). At the time of the report, AMNESIA (memory problem), HOT FLUSH (hot flashes), DYSPNOEA (trouble in breathing) and NAUSEA (Nausea) outcome was unknown, SARS-COV-2 TEST POSITIVE (covid 19 positive), CHEST PAIN (chest pain) and INFLUENZA LIKE ILLNESS (flu like symptoms) had resolved and FEELING ABNORMAL (brain fog) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided.     Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: TCR On 10-May-2021: Follow-up :- Email id updated
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Nausea, SARS-CoV-2 test positive
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (memory problem), HOT FLUSH (hot flashes), DYSPNOEA (trouble in breathing), SARS-COV-2 TEST POSITIVE (covid 19 positive) and CHEST PAIN (chest pain) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN CALCIUM (LIPITOR), ALFUZOSIN HYDROCHLORIDE (ALFUSIN) and METFORMIN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced AMNESIA (memory problem), HOT FLUSH (hot flashes) and DYSPNOEA (trouble in breathing). On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (covid 19 positive), CHEST PAIN (chest pain), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (brain fog) and NAUSEA (Nausea). At the time of the report, AMNESIA (memory problem), HOT FLUSH (hot flashes), DYSPNOEA (trouble in breathing) and NAUSEA (Nausea) outcome was unknown, SARS-COV-2 TEST POSITIVE (covid 19 positive), CHEST PAIN (chest pain) and INFLUENZA LIKE ILLNESS (flu like symptoms) had resolved and FEELING ABNORMAL (brain fog) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided.     Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: TCR On 10-May-2021: Follow-up :- Email id updated
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Diarrhoea, Dizziness
Clinical narrative: cough; shortness of breath; runny nose; Neck pain; diarrhea; chills; headache; fever; Joint pain/ Twinge below my elbow; light headed; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose), NECK PAIN (Neck pain) and DIARRHOEA (diarrhea) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced DIZZINESS (light headed). On 16-Mar-2021, the patient experienced COUGH (cough), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose), NECK PAIN (Neck pain), DIARRHOEA (diarrhea), CHILLS (chills), HEADACHE (headache), PYREXIA (fever) and ARTHRALGIA (Joint pain/ Twinge below my elbow). At the time of the report, COUGH (cough), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose), NECK PAIN (Neck pain), DIARRHOEA (diarrhea), DIZZINESS (light headed), CHILLS (chills), HEADACHE (headache), PYREXIA (fever) and ARTHRALGIA (Joint pain/ Twinge below my elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  The patient did not receive treatment.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Neck pain, Pyrexia, Rhinorrhoea
Clinical narrative: cough; shortness of breath; runny nose; Neck pain; diarrhea; chills; headache; fever; Joint pain/ Twinge below my elbow; light headed; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose), NECK PAIN (Neck pain) and DIARRHOEA (diarrhea) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced DIZZINESS (light headed). On 16-Mar-2021, the patient experienced COUGH (cough), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose), NECK PAIN (Neck pain), DIARRHOEA (diarrhea), CHILLS (chills), HEADACHE (headache), PYREXIA (fever) and ARTHRALGIA (Joint pain/ Twinge below my elbow). At the time of the report, COUGH (cough), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose), NECK PAIN (Neck pain), DIARRHOEA (diarrhea), DIZZINESS (light headed), CHILLS (chills), HEADACHE (headache), PYREXIA (fever) and ARTHRALGIA (Joint pain/ Twinge below my elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  The patient did not receive treatment.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Sleep disorder
Clinical narrative: Can't even sleep; Weak; Tired; Dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), SLEEP DISORDER (Can't even sleep), ASTHENIA (Weak), HEADACHE (Headache) and FATIGUE (Tired) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced DIZZINESS (Dizziness) and HEADACHE (Headache). On an unknown date, the patient experienced SLEEP DISORDER (Can't even sleep), ASTHENIA (Weak) and FATIGUE (Tired). At the time of the report, DIZZINESS (Dizziness), SLEEP DISORDER (Can't even sleep), ASTHENIA (Weak) and FATIGUE (Tired) outcome was unknown and HEADACHE (Headache) had not resolved. Not Provided          Patient was taking diabetes medication.  No treatment information was provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: 32 weeks pregnant;received 1st dose of Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (32 weeks pregnant;received 1st dose of Moderna vaccine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036a21a) for COVID-19 vaccination.     Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], LEVOTHYROXINE, VITAMIN D [VITAMIN D NOS] and MAGNESIUM for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-Aug-2020 and the estimated date of delivery was 16-May-2021. On 22-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (32 weeks pregnant;received 1st dose of Moderna vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  On 22-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (32 weeks pregnant;received 1st dose of Moderna vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Sep-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: A little soreness in the injected arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little soreness in the injected arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Fever (A high fever of 102 F.) since March 2021.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (A little soreness in the injected arm). At the time of the report, PAIN IN EXTREMITY (A little soreness in the injected arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Additional information received on 09-May-2021 had an event added which is soreness in the injected arm.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: Warm to the touch knot at the site of injection; Warm to the touch knot at the site of injection; Red knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE INDURATION (Warm to the touch knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE INDURATION (Warm to the touch knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE INDURATION (Warm to the touch knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: first dose of Moderna COVID19 vaccine 03feb2021 and is scheduled for the second dose  tomorrow, 23mar2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose of Moderna COVID19 vaccine 03feb2021 and is scheduled for the second dose  tomorrow, 23mar2021) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ULUMZ(U/O)A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose of Moderna COVID19 vaccine 03feb2021 and is scheduled for the second dose  tomorrow, 23mar2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose of Moderna COVID19 vaccine 03feb2021 and is scheduled for the second dose  tomorrow, 23mar2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were reported. No relevant concomitant medications were reported.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: ULUMZ(U/O)A) with no associated AEs.